Desmoid: The role of local therapy in an era of systemic options

Current Treatment Options in Oncology

Volumn 14, Issue 3, 2013, Pages 465-473

  Walczak, Brian E ^a   Rose, Peter S ^a  

^a MAYO CLINIC   (United States)

Author keywords

catenin; Aggressive fibromatosis; Chemical ablation; Chemotherapy; Cryoablation; Desmoid tumor; Musculoaponeurotic fibromatosis; Radiation therapy

Indexed keywords

ACETIC ACID; ALCOHOL; BETA CATENIN; IMATINIB;

APC GENE; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CRYOABLATION; CTNNB1 GENE; DESMOID TUMOR; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GENE; GENE MUTATION; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIMB PRESERVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PRESERVATION; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; R0 RESECTION; RADIATION DOSE; RADIOTHERAPY; RECURRENCE FREE SURVIVAL;

BETA CATENIN; COMBINED MODALITY THERAPY; DRUG THERAPY; FIBROMATOSIS, AGGRESSIVE; HUMANS; MAF TRANSCRIPTION FACTORS; NEOPLASM RECURRENCE, LOCAL;

EID: 84884204975     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-013-0235-7     Document Type: Article

References (31)

1. Gronchi A, Casali PG, Mariani, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-7.
2. Merchant NB, Lewis JJ, Woodruff JM, et al. Extremity and trunk desmoid tumors. Cancer. 1999;86:2045-52.
3. Pritchard DJ, Nascimento AG, Petersen IA. Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1996;78-A:848-54.
4. Molloy AP, Hutchinson B, O'Toole GC. Extra-abdominal desmoid tumours: a review of the literature. Sarcoma. 2012;2012:1-9.
5. Escobar C, Munker R, Thomas JO, et al. Update on desmoid tumors. Ann Oncol. 2012;23:562-9.
6. Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol. 2010;102:380-4.
7. Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor: not a benign disease. Arch Surg. 1989;124:191-6.
8. Rock MG, Pritchard DJ, Reiman HM, et al. Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984;66:1369-74.
9. Okuno SH. The enigma of desmoid tumors. Curr Treat Options Oncol. 2006;7:438-43.
10. McDougall A, McGarrity G. Extra-abdominal desmoid tumours. J Bone Joint Surg Br. 1979;61-B:373-7.
11. Mullen JT, DeLaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol. 2012;19:4028-35. Analysized prognostic factors of surgically treated desmoid tumors. Reported the goal of surgically treated desmoid tumors is function-sparing surgery with wide excision with negative margins when possible. Adjuvant radiation therapy was used selectively to improve local control in patients with positive margins.
12. Weiss SW, Goldblum JR, Enzinger FM. Enzinger and Weiss's soft tissue tumors. In: Weiss SW, Goldblum JR, editors. Fibromatoses. 5th ed. Philadelphia: Mosby Elsevier; 2001. p. 227-56.
13. Soule EH, Scanlon PW. Fibrosarcoma arising in an extraabdominal desmoid tumor: report of case. Mayo Clin Proc. 1962;37:443.
14. Bonvalot S, Desai A, Coppola S, et al. The treatment of desmoid tumors: a stepwise clinical approach. Ann Oncol. 2012;23:158-66. Proposed a treatment algorithm with more conservative approach to treatment.
15. Biermann JS. Desmoid tumors. Curr treat options oncol. 2000;1:262-6.
16. Lucas DR, Shroyer KR, McCarthy PJ, et al. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol. 1997;21:306-11.
17. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25:1785-91.
18. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29:3553-8. Demonstrated that in select subgroup of patients (desmoid tumors in non-threatening locations or at risk for mutilating surgery), observation resulted in stable or regressive disease in 21/27 patients. Although, 6/27 patients had progressive disease, all patient stabilized by the end of their follow-up.
19. Lazar A, Tuvin D, Hajibashi S, et al. Specific mutations in the β- catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518-27.
20. Kasper B, Dimitrakopoulou-Strauss A, Strauss LG, et al. Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib. Eur J Nucl Med Mol Imaging. 2010;37:1876-82.
21. von Mehren M, Benjamin RS, Bui MM, et al. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10:951-60. Reported updated guidelines in the management of desmoid tumors.
22. Leithner A, Gapp M, Leithner K, et al. Margins in extra-abdominal desmoid tumors: a comparative analysis. J Surg Oncol. 2004;86:152-6.
23. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17:158-67.
24. Leibel SAS, Wara WMW, Hill DRD, et al. Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys. 1983;9:1167-71.
25. Nuyttens JJ, Rust PF, Thomas CR, et al. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. Cancer. 2000;88:1517-23.
26. Fontanesi JJ, Mott MPM, Kraut MJM, et al. The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors. Sarcoma. 2004;8:83-6.
27. Rutenberg MS, Indelicato DJ, Knapik JA, et al. External-beam radiotherapy for pediatric and young adult desmoid tumors. Pediatr Blood Cancer. 2010;57:435-42.
28. Kujak JL, Liu PT, Johnson GB, et al. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 2010;39:175-82.
29. Clark TW. Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol. 2003;14:629-33.
30. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998;40:637-45.
31. Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16:2587-93.